Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2117]

Improving treatment for aggressive brain tumours

Improving treatment for aggressive brain tumours

Metabolic protein launches sugar feast that nurtures brain tumours

Metabolic protein launches sugar feast that nurtures brain tumours

Patient's own immune cells may blunt viral therapy for brain cancer

Patient's own immune cells may blunt viral therapy for brain cancer

Uninsured brain cancer patients may be more likely than insured to die after surgery to remove tumour

Uninsured brain cancer patients may be more likely than insured to die after surgery to remove tumour

A link in a protein between ALS and cancer

A link in a protein between ALS and cancer

First trial in humans of “minicells”: a completely new way of delivering anti-cancer drugs

First trial in humans of “minicells”: a completely new way of delivering anti-cancer drugs

Mesothelioma drug slows disease progression in patients with an inactive NF2 gene

Mesothelioma drug slows disease progression in patients with an inactive NF2 gene

Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy

Drug combination shrinks secondary brain tumours in breast cancer without substantial side effects of radiotherapy

ASTRO 2012: Memantine delays cognitive decline in brain tumour patients who receive whole brain radiation therapy

ASTRO 2012: Memantine delays cognitive decline in brain tumour patients who receive whole brain radiation therapy

Anti-alcoholism drug could help treat most common type of adult brain cancer

Anti-alcoholism drug could help treat most common type of adult brain cancer

More from ecancer